Octreotide pamoate long-acting formulation
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Octreotide pamoate long-acting formulation, covering 2015-12-03 to 2015-12-03. Get the full timeline:
Most recent: Clinical Trial Update: Open Label Study of a Single Dose of a New Extended Long Acting Formulation of Octreotide Pamoate in Healthy Volunteers [Phase 1]